Atara Biotherapeutics

atarabio.com

Atara Biotherapeutics is a leading "off-the-shelf" T-cell immunotherapy company developing novel treatments for patients with cancer and autoimmune diseases. Originating from over a decade of ground-breaking clinical experience at Memorial Sloan Kettering and QIMR Berghofer, Atara’s T-cell immunotherapies are designed to precisely recognize and eliminate cancerous or diseased cells without affecting normal, healthy cells. Our “off-the-shelf”, or allogeneic, T-cells are engineered from donors with healthy immune function and allow for rapid delivery to patients without a requirement for pre-treatment. Atara’s most advanced T-cell immunotherapy in development, ATA129, is being developed for the treatment of cancer patients with rituximab refractory Epstein-Barr virus (EBV) associated post-transplant lymphoproliferative disorder (EBV-PTLD), as well as other EBV positive hematologic and solid tumors including nasopharyngeal carcinoma (NPC). ATA188, the Company’s next generation T-cell immunotherapy for autoimmune diseases, selectively targets specific EBV antigens believed to be important for the potential treatment of multiple sclerosis (MS). Working at Atara Atara is a 130+ person publicly traded (Nasdaq: ATRA) clinical-stage biotechnology company. We are co-located by design in Westlake Village, CA (northwest LA) and South San Francisco, CA, with a process development lab in the Denver, CO area and an office in New York City. We are also constructing a ~90,000 sq. ft. multi-product manufacturing and R&D facility in Thousand Oaks, CA that will bring together all our southern CA employees and operations.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Chemical Management

PIPESTONE ENERGY CORP. ANNOUNCES RENEWAL OF NORMAL COURSE ISSUER BID

Pipestone Energy Corp. | November 24, 2022

news image

Pipestone Energy Corp. is pleased to announce the Toronto Stock Exchange has accepted the notice filed by the Company to renew its normal course issuer bid. Pipestone’s inaugural NCIB was launched in November 2021 and has been fully executed with the purchase and cancellation of 9,598,347 common shares of the Company for an average price of $4.44 per share. The NCIB allows Pipestone to purchase up to 13,936,907 Common Shares, representing 5% of its 278,738,148 outstanding Co...

Read More

Chemical Technology, Chemical Management

ALBEMARLE UNVEILS MERCLOK™, INNOVATIVE TECHNOLOGY FOR MERCURY REMEDIATION

Albemarle Corporation | December 09, 2022

news image

Albemarle Corporation a leader in the global specialty chemicals industry, unveiled a breakthrough product that captures mercury from soil and mining waste, helping to remove this harmful element from the food chain. MercLok™ is a soil treatment for mercury remediation. Known in the industry as an amendment, MercLok cost-effectively captures mercury in soil, mining waste and, through in-ground treatment, groundwater over the long term, capturing the potent and highly mobile ...

Read More

DECK 7 OPTIMIZES ITS STRATEGIC MARKETING FOR 2020 USING A REVISED ABM STRATEGY

DECK 7 | February 04, 2020

news image

Being one of the best lead-gen service providers in San Diego, California, DECK 7 is more data-focused than ever. The brand has optimized its strategic marketing approach by scaling ABM in a number of effective ways. By combining its time-tested ABM framework with a strong data-driven approach, DECK 7 is empowering numerous brands in maximizing growth and driving actionable results. DECK 7’s ABM prowess is defined by its skilled team members and their advanced approach to B2B marketing. Th...

Read More

Chemical Technology

NIH GRANT SUPPORTS NEUFELDT’S FUNDAMENTAL RESEARCH INTO CHEMICAL REACTIONS

NIH | November 27, 2020

news image

A natural physicist zeroing in on metal impetuses is the most recent Montana State University specialist to have their work perceived and subsidized through a National Institutes of Health program with an accentuation on examining wide logical inquiries. Sharon Neufeldt, an associate teacher in the Department of Chemistry and Biochemistry in MSU's College of Letters and Science, gotten the Maximizing Investigators' Research Award through the NIH's National Institute of...

Read More
news image

Chemical Management

PIPESTONE ENERGY CORP. ANNOUNCES RENEWAL OF NORMAL COURSE ISSUER BID

Pipestone Energy Corp. | November 24, 2022

Pipestone Energy Corp. is pleased to announce the Toronto Stock Exchange has accepted the notice filed by the Company to renew its normal course issuer bid. Pipestone’s inaugural NCIB was launched in November 2021 and has been fully executed with the purchase and cancellation of 9,598,347 common shares of the Company for an average price of $4.44 per share. The NCIB allows Pipestone to purchase up to 13,936,907 Common Shares, representing 5% of its 278,738,148 outstanding Co...

Read More
news image

Chemical Technology, Chemical Management

ALBEMARLE UNVEILS MERCLOK™, INNOVATIVE TECHNOLOGY FOR MERCURY REMEDIATION

Albemarle Corporation | December 09, 2022

Albemarle Corporation a leader in the global specialty chemicals industry, unveiled a breakthrough product that captures mercury from soil and mining waste, helping to remove this harmful element from the food chain. MercLok™ is a soil treatment for mercury remediation. Known in the industry as an amendment, MercLok cost-effectively captures mercury in soil, mining waste and, through in-ground treatment, groundwater over the long term, capturing the potent and highly mobile ...

Read More
news image

DECK 7 OPTIMIZES ITS STRATEGIC MARKETING FOR 2020 USING A REVISED ABM STRATEGY

DECK 7 | February 04, 2020

Being one of the best lead-gen service providers in San Diego, California, DECK 7 is more data-focused than ever. The brand has optimized its strategic marketing approach by scaling ABM in a number of effective ways. By combining its time-tested ABM framework with a strong data-driven approach, DECK 7 is empowering numerous brands in maximizing growth and driving actionable results. DECK 7’s ABM prowess is defined by its skilled team members and their advanced approach to B2B marketing. Th...

Read More
news image

Chemical Technology

NIH GRANT SUPPORTS NEUFELDT’S FUNDAMENTAL RESEARCH INTO CHEMICAL REACTIONS

NIH | November 27, 2020

A natural physicist zeroing in on metal impetuses is the most recent Montana State University specialist to have their work perceived and subsidized through a National Institutes of Health program with an accentuation on examining wide logical inquiries. Sharon Neufeldt, an associate teacher in the Department of Chemistry and Biochemistry in MSU's College of Letters and Science, gotten the Maximizing Investigators' Research Award through the NIH's National Institute of...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us